AHA科学声明：冠状动脉旁路移植术后二级预防

2015-02-11 CMT 医学论坛网

2月9日，美国心脏学会(AHA)在《循环》(Circulation)杂志上发布了《AHA科学声明：冠状动脉旁路移植术后二级预防》。 AHA科学声明：冠状动脉旁路移植术后二级预防之抗血小板治疗建议、抗栓治疗建议、β受体阻滞剂治疗先来点击下载文献原文吧：下载：Secondary Prevention After Coronary Artery Bypass Graft Surgery

2月9日，美国心脏学会(AHA)在《循环》(Circulation)杂志上发布了《AHA科学声明：冠状动脉旁路移植术后二级预防》。

AHA科学声明：冠状动脉旁路移植术后二级预防之抗血小板治疗建议、抗栓治疗建议、β受体阻滞剂治疗

推荐建议	推荐级别
1、冠状动脉旁路移植（CABG）术前和术后6小时内应该用阿司匹林，推荐剂量为81—325 mg/d，然后继续使用阿司匹林，无明确期限，以减少移植闭塞和不良心脏事件。	1类推荐，A级证据
2、非体外循环CABG(off-pump CABG)术后，应用阿司匹林（81–162 mg /d）联合氯吡格雷（75 mg/ d）的双联抗血小板治疗达1年。	1类推荐，A级证据
3、对于CABG术后因阿司匹林不耐受或者过敏的患者，氯吡格雷（75 mg/ d）是其合理选择，继续无限制使用氯吡格雷是合理的。	IIa类推荐，C级证据
4、对于急性冠脉综合征患者，虽然有关CABG人群的前瞻性临床研究数据尚缺乏，但CABG术后给予其阿司匹林联合普拉格雷或替格瑞洛（首选氯吡格雷）是合理的。	IIa类推荐，B级证据
5、CABG术后进行单一抗血小板治疗，考虑更高剂量的阿司匹林（325 mg /d，而非81 mg/ d）是合理的，大概是为了防止阿司匹林抵抗，但患者获益尚不十分明确。	IIa类推荐，A级证据
6、对于近期无急性冠脉综合征的患者，体外循环CABG(on-pump CABG)术后可考虑给予其1年的阿司匹林联合氯吡格雷双联抗血小板治疗。	IIb类推荐，A级证据

先来点击下载文献原文吧：

下载：Secondary Prevention After Coronary Artery Bypass Graft Surgery

A Scientific Statement From the American Heart Association

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2018962, encodeId=e2172018962c7, content=<a href='/topic/show?id=b2f35881810' target=_blank style='color:#2F92EE;'>#旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58818, encryptionId=b2f35881810, topicName=旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Thu Apr 02 06:30:00 CST 2015, time=2015-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16172, encodeId=c6ef161e20f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:49:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15766, encodeId=cef015e662f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:01:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15549, encodeId=fc731554994, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:41:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15456, encodeId=4f3d15456ff, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 13:43:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267254, encodeId=8b8e126e25475, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355479, encodeId=c6ae13554e960, content=<a href='/topic/show?id=f0ff308e898' target=_blank style='color:#2F92EE;'>#冠状动脉旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30878, encryptionId=f0ff308e898, topicName=冠状动脉旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998876, encodeId=cea919988e625, content=<a href='/topic/show?id=8e2ee5200ee' target=_blank style='color:#2F92EE;'>#移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75200, encryptionId=8e2ee5200ee, topicName=移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Feb 19 09:30:00 CST 2015, time=2015-02-19, status=1, ipAttribution=)]
2015-04-02 AspirantSuo

#旁路移植术#

64 0
[GetPortalCommentsPageByObjectIdResponse(id=2018962, encodeId=e2172018962c7, content=<a href='/topic/show?id=b2f35881810' target=_blank style='color:#2F92EE;'>#旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58818, encryptionId=b2f35881810, topicName=旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Thu Apr 02 06:30:00 CST 2015, time=2015-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16172, encodeId=c6ef161e20f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:49:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15766, encodeId=cef015e662f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:01:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15549, encodeId=fc731554994, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:41:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15456, encodeId=4f3d15456ff, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 13:43:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267254, encodeId=8b8e126e25475, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355479, encodeId=c6ae13554e960, content=<a href='/topic/show?id=f0ff308e898' target=_blank style='color:#2F92EE;'>#冠状动脉旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30878, encryptionId=f0ff308e898, topicName=冠状动脉旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998876, encodeId=cea919988e625, content=<a href='/topic/show?id=8e2ee5200ee' target=_blank style='color:#2F92EE;'>#移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75200, encryptionId=8e2ee5200ee, topicName=移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Feb 19 09:30:00 CST 2015, time=2015-02-19, status=1, ipAttribution=)]
2015-02-17 chinayinhan

已阅

117 0
[GetPortalCommentsPageByObjectIdResponse(id=2018962, encodeId=e2172018962c7, content=<a href='/topic/show?id=b2f35881810' target=_blank style='color:#2F92EE;'>#旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58818, encryptionId=b2f35881810, topicName=旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Thu Apr 02 06:30:00 CST 2015, time=2015-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16172, encodeId=c6ef161e20f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:49:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15766, encodeId=cef015e662f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:01:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15549, encodeId=fc731554994, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:41:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15456, encodeId=4f3d15456ff, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 13:43:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267254, encodeId=8b8e126e25475, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355479, encodeId=c6ae13554e960, content=<a href='/topic/show?id=f0ff308e898' target=_blank style='color:#2F92EE;'>#冠状动脉旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30878, encryptionId=f0ff308e898, topicName=冠状动脉旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998876, encodeId=cea919988e625, content=<a href='/topic/show?id=8e2ee5200ee' target=_blank style='color:#2F92EE;'>#移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75200, encryptionId=8e2ee5200ee, topicName=移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Feb 19 09:30:00 CST 2015, time=2015-02-19, status=1, ipAttribution=)]
2015-02-16 windmilL1989

赞

157 0
[GetPortalCommentsPageByObjectIdResponse(id=2018962, encodeId=e2172018962c7, content=<a href='/topic/show?id=b2f35881810' target=_blank style='color:#2F92EE;'>#旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58818, encryptionId=b2f35881810, topicName=旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Thu Apr 02 06:30:00 CST 2015, time=2015-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16172, encodeId=c6ef161e20f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:49:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15766, encodeId=cef015e662f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:01:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15549, encodeId=fc731554994, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:41:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15456, encodeId=4f3d15456ff, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 13:43:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267254, encodeId=8b8e126e25475, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355479, encodeId=c6ae13554e960, content=<a href='/topic/show?id=f0ff308e898' target=_blank style='color:#2F92EE;'>#冠状动脉旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30878, encryptionId=f0ff308e898, topicName=冠状动脉旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998876, encodeId=cea919988e625, content=<a href='/topic/show?id=8e2ee5200ee' target=_blank style='color:#2F92EE;'>#移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75200, encryptionId=8e2ee5200ee, topicName=移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Feb 19 09:30:00 CST 2015, time=2015-02-19, status=1, ipAttribution=)]
2015-02-15 jianlion

恩恩

153 0
[GetPortalCommentsPageByObjectIdResponse(id=2018962, encodeId=e2172018962c7, content=<a href='/topic/show?id=b2f35881810' target=_blank style='color:#2F92EE;'>#旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58818, encryptionId=b2f35881810, topicName=旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Thu Apr 02 06:30:00 CST 2015, time=2015-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16172, encodeId=c6ef161e20f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:49:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15766, encodeId=cef015e662f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:01:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15549, encodeId=fc731554994, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:41:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15456, encodeId=4f3d15456ff, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 13:43:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267254, encodeId=8b8e126e25475, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355479, encodeId=c6ae13554e960, content=<a href='/topic/show?id=f0ff308e898' target=_blank style='color:#2F92EE;'>#冠状动脉旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30878, encryptionId=f0ff308e898, topicName=冠状动脉旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998876, encodeId=cea919988e625, content=<a href='/topic/show?id=8e2ee5200ee' target=_blank style='color:#2F92EE;'>#移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75200, encryptionId=8e2ee5200ee, topicName=移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Feb 19 09:30:00 CST 2015, time=2015-02-19, status=1, ipAttribution=)]
2015-02-15 午夜星河

明白

170 0
[GetPortalCommentsPageByObjectIdResponse(id=2018962, encodeId=e2172018962c7, content=<a href='/topic/show?id=b2f35881810' target=_blank style='color:#2F92EE;'>#旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58818, encryptionId=b2f35881810, topicName=旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Thu Apr 02 06:30:00 CST 2015, time=2015-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16172, encodeId=c6ef161e20f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:49:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15766, encodeId=cef015e662f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:01:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15549, encodeId=fc731554994, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:41:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15456, encodeId=4f3d15456ff, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 13:43:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267254, encodeId=8b8e126e25475, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355479, encodeId=c6ae13554e960, content=<a href='/topic/show?id=f0ff308e898' target=_blank style='color:#2F92EE;'>#冠状动脉旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30878, encryptionId=f0ff308e898, topicName=冠状动脉旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998876, encodeId=cea919988e625, content=<a href='/topic/show?id=8e2ee5200ee' target=_blank style='color:#2F92EE;'>#移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75200, encryptionId=8e2ee5200ee, topicName=移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Feb 19 09:30:00 CST 2015, time=2015-02-19, status=1, ipAttribution=)]
2015-02-13 zhaohui6731

#AHA#

51 0
[GetPortalCommentsPageByObjectIdResponse(id=2018962, encodeId=e2172018962c7, content=<a href='/topic/show?id=b2f35881810' target=_blank style='color:#2F92EE;'>#旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58818, encryptionId=b2f35881810, topicName=旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Thu Apr 02 06:30:00 CST 2015, time=2015-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16172, encodeId=c6ef161e20f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:49:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15766, encodeId=cef015e662f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:01:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15549, encodeId=fc731554994, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:41:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15456, encodeId=4f3d15456ff, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 13:43:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267254, encodeId=8b8e126e25475, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355479, encodeId=c6ae13554e960, content=<a href='/topic/show?id=f0ff308e898' target=_blank style='color:#2F92EE;'>#冠状动脉旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30878, encryptionId=f0ff308e898, topicName=冠状动脉旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998876, encodeId=cea919988e625, content=<a href='/topic/show?id=8e2ee5200ee' target=_blank style='color:#2F92EE;'>#移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75200, encryptionId=8e2ee5200ee, topicName=移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Feb 19 09:30:00 CST 2015, time=2015-02-19, status=1, ipAttribution=)]
2015-02-13 zhaojie88

#冠状动脉旁路移植术#

72 0
[GetPortalCommentsPageByObjectIdResponse(id=2018962, encodeId=e2172018962c7, content=<a href='/topic/show?id=b2f35881810' target=_blank style='color:#2F92EE;'>#旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58818, encryptionId=b2f35881810, topicName=旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Thu Apr 02 06:30:00 CST 2015, time=2015-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16172, encodeId=c6ef161e20f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:49:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15766, encodeId=cef015e662f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:01:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15549, encodeId=fc731554994, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:41:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15456, encodeId=4f3d15456ff, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 13:43:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267254, encodeId=8b8e126e25475, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355479, encodeId=c6ae13554e960, content=<a href='/topic/show?id=f0ff308e898' target=_blank style='color:#2F92EE;'>#冠状动脉旁路移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30878, encryptionId=f0ff308e898, topicName=冠状动脉旁路移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 13 00:30:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998876, encodeId=cea919988e625, content=<a href='/topic/show?id=8e2ee5200ee' target=_blank style='color:#2F92EE;'>#移植术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75200, encryptionId=8e2ee5200ee, topicName=移植术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Feb 19 09:30:00 CST 2015, time=2015-02-19, status=1, ipAttribution=)]
2015-02-19 cy0324

#移植术#

68 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管

AHA科学声明：冠状动脉旁路移植术后二级预防

推荐建议

推荐级别

1、冠状动脉旁路移植（CABG）术前和术后6小时内应该用阿司匹林，推荐剂量为81—325 mg/d，然后继续使用阿司匹林，无明确期限，以减少移植闭塞和不良心脏事件。

1类推荐，A级证据

2、非体外循环CABG(off-pump CABG)术后，应用阿司匹林（81–162 mg /d）联合氯吡格雷（75 mg/ d）的双联抗血小板治疗达1年。

1类推荐，A级证据

3、对于CABG术后因阿司匹林不耐受或者过敏的患者，氯吡格雷（75 mg/ d）是其合理选择，继续无限制使用氯吡格雷是合理的。

IIa类推荐，C级证据

4、对于急性冠脉综合征患者，虽然有关CABG人群的前瞻性临床研究数据尚缺乏，但CABG术后给予其阿司匹林联合普拉格雷或替格瑞洛（首选氯吡格雷）是合理的。

IIa类推荐，B级证据

5、CABG术后进行单一抗血小板治疗，考虑更高剂量的阿司匹林（325 mg /d，而非81 mg/ d）是合理的，大概是为了防止阿司匹林抵抗，但患者获益尚不十分明确。

IIa类推荐，A级证据

6、对于近期无急性冠脉综合征的患者，体外循环CABG(on-pump CABG)术后可考虑给予其1年的阿司匹林联合氯吡格雷双联抗血小板治疗。

IIb类推荐，A级证据

相关资讯

科室

工具

服务